GeneGo Licenses MetaCore Data Analysis Suite to AVEO Pharmaceuticals
ST. JOSEPH, Mich., Oct. 23 /PRNewswire/ -- GeneGo, Inc., a leading provider of software and databases for systems biology, today announced that they have licensed their MetaCore Data Mining Suite to AVEO Pharmaceuticals. The latest version, MetaCore 4.5, includes novel GeneGo disease enrichmen...Breakthrough model for human cancer may improve development of cancer drugs; study in PNAS
... CAMBRIDGE, Mass., April 6, 2009 aveo Pharmaceuticals, Inc., a biopharmaceutical company...human-in-mouse (HIM) cancer model system, in which aveo successfully created invasive human tumors from pr...mal models in the preclinical development phases. aveo scientists have developed a sophisticated cancer b...AVEO Pharmaceuticals Novel Oncology Research Platform and Clinical Pipeline to Be Featured at AACR
...ommunity the pioneering oncology research platform aveo has developed, which we believe may significantly ...herapies," said Tuan Ha-Ngoc, president and CEO of aveo Pharmaceuticals. "AVEO is focusing on translating ...use Models of Cancer - Section 21, Board 8 About aveo ...